RAPS: EU Regulators Concerned About Drug Data Fraud by Indian Company
11.12.2014
European regulatory officials have expressed concern that dozens of medicines may have been approved in the EU based on fraudulent data conducted by a contract testing facility in Hyderabad, India.
SciencePharma
